Mannkind (MNKD) Operating Expenses (2010 - 2026)
Mannkind (MNKD) reported Operating Expenses of $91.8 million for Q1 2026, up 63.82% year-over-year from $56.1 million in Q1 2025, and down 23.24% quarter-over-quarter from $119.6 million in Q4 2025.
Mannkind (MNKD) Operating Expenses (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Operating Expenses data on file, last reported at $91.8 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $91.8 million, up 63.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $345.9 million (up 57.65% YoY), and the FY2025 annual result was $310.2 million, up 45.67% from the prior year.
- Operating Expenses retreated to $91.8 million in Q1 2026 per MNKD's latest filing, from $119.6 million in the prior quarter.
- Over five years, Operating Expenses peaked at $119.6 million in Q4 2025 and troughed at $33.2 million in Q1 2022.
- A 5-year average of $57.0 million and a median of $50.3 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses decreased 0.66% in 2024, then surged 137.95% in 2025.
- A 5-year view of Operating Expenses shows it stood at $48.8 million in 2022, then grew by 3.61% to $50.6 million in 2023, then decreased by 0.66% to $50.3 million in 2024, then surged by 137.95% to $119.6 million in 2025, then declined by 23.24% to $91.8 million in 2026.
- Business Quant data shows MNKD's Operating Expenses at $91.8 million in Q1 2026, $119.6 million in Q4 2025, and $63.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 91.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.84 Mn |
| Dec 31, 2025 | 119.64 Mn |
| Sep 30, 2025 | 63.23 Mn |
| Jun 30, 2025 | 71.23 Mn |
| Mar 31, 2025 | 56.06 Mn |
| Dec 31, 2024 | 50.28 Mn |
| Sep 30, 2024 | 57.32 Mn |
| Jun 30, 2024 | 55.78 Mn |
| Mar 31, 2024 | 49.54 Mn |
| Dec 31, 2023 | 50.61 Mn |
| Sep 30, 2023 | 46.16 Mn |
| Jun 30, 2023 | 46.89 Mn |
| Mar 31, 2023 | 46.62 Mn |
| Dec 31, 2022 | 48.85 Mn |
| Sep 30, 2022 | 42.44 Mn |
| Jun 30, 2022 | 39.35 Mn |
| Mar 31, 2022 | 33.25 Mn |
| Dec 31, 2021 | 36.48 Mn |
| Sep 30, 2021 | 28.80 Mn |
| Jun 30, 2021 | 33.55 Mn |